{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:06:59Z","timestamp":1704308819877},"reference-count":7,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4223,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> Moccasin\u2010type tinea pedis (MTTP) is characterized by hyperkeratosis of the sole, which is generally refractory to treatment. As topical application of an antimycotic agent alone often fails to control this disease, oral griseofulvin is commonly used. We attempted the treatment of MTTP with topical bifonazole (Mycospor Solution) alone (group I) or in combination with 10% urea ointment (Urepearl\u00ae) (group II) and compared the clinical benefit of these two therapies. The clinical improvement rate (percentage of \u2018marked improvement\u2019 plus \u2018moderate improvement\u2019) was 46.2% in group 1 and 83.3% in group II. The fungal eradication rate was 6.7% in group I and 26.7% in group II after 4 weeks of treatment and was 40% and 80%, respectively, after 12 weeks. The utility rate (percentage of \u2018beneficial\u2019 plus \u2018very beneficial\u2019) was 46.7% in group I and 86.7% in group II. These results indicate the superiority of combined therapy with 1% bifonazole solution and 10% urea ointment for the treatment of MTTP and suggest that this combination therapy can be recommended for patients for whom it is difficult to use oral griseofulvin or for patients who fail to respond to oral griseofulvin alone.<\/jats:p><jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Die Tinea pedis vom Mokassintyp (MTTP) ist durch Hyperkeratose der Fu\u00dfsohle gekennzeichnet und widersteht \u00fcblicherweise der Behandlung. Da diese Krankheit durch alleinige topische Applikation eines Antimy\u2010kotikums meist nicht bek\u00e4mpft werden kann, wird allgemein orales Griseofulvin verwendet. Wir haben versucht, MTTP mit topischem Bifonazol (Mycospor\u00ae L\u00f6sung) allein (Gruppe I) oder in Kombination mit 10% Harnstoffsalbe (Urepearl\u00ae) (Gruppe II) zu behandeln und die klinische Wirksamkeit beider Therapien zu vergleichen. Der klinische Besserungsgrad betrug 46.2% in Gruppe I und 83.3% in Gruppe II. Die Pilzeradikationsrate betrug 6.7% in Gruppe I und 26.7% in Gruppe II nach einer Behandlungszeit von 4 Wochen und 40% bzw. 80% nach 12 Wochen. Die Wirksamkeitsrate betrug 46.7% in Gruppe I und 86.7% in Gruppe II. Diese Ergebnisse belegen die \u00dcberlegenheit der Kombinationstherapie mit 1% Bifonazol\u2010L\u00f6sung und 10% Harnstoffsalbe bei Behandlung der MTTP und deuten darauf hin, da\u00df sich diese Kombinationstherapie f\u00fcr Patienten empfehlen l\u00e4\u00dft, bei denen die Applikation des oralen Griseofulvins problematisch ist oder die auf orales Griseofulvin allein nicht reagieren.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1997.tb00219.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:46:48Z","timestamp":1240591608000},"page":"223-228","source":"Crossref","is-referenced-by-count":11,"title":["Clinical evaluation of bifonazole for moccasin\u2010type tinea pedis"],"prefix":"10.1111","volume":"40","author":[{"given":"H.","family":"Tanuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archderm.1981.01650010022016","article-title":"Griseofulvin resistant dermatophytosis correlates with in vitro resistance","volume":"117","author":"Aris W. M.","year":"1981","journal-title":"Arch. Dermatol."},{"key":"e_1_2_1_3_2","first-page":"1783","article-title":"Experience of treatment with econazole cream and Urepearl\u00ae combination for dyshidrotic trichophytosis (hyperkeratotic type) and treatment with econazole cream for dermatomycosis with secondary infection","volume":"6","author":"Yamaguchi Z.","year":"1981","journal-title":"J. Med. Pharmaceut. Sci."},{"key":"e_1_2_1_4_2","first-page":"127","article-title":"Experience of treatment with 10% urea ointment (Urepearl\u00ae) and econazole nitrate (Palavale\u00ae cream) combination for hyperkeratotic type tinea pedis","volume":"33","author":"Doi H.","year":"1984","journal-title":"J. New Remedies Clinics"},{"key":"e_1_2_1_5_2","unstructured":"Plempel M.&Regal E.(1982)Antimycotic properties of the topical azole bifonazolein vitroandin vivo. International Antifungal Symposium. Excerpta Medica. Tokyo 1982 pp.29\u201336."},{"key":"e_1_2_1_6_2","unstructured":"Plempel M.(1982)Bifonazole\u2014clotrimazole comparison of the properties and in actionsin vitroandin vivo.Bayer AG data 6."},{"key":"e_1_2_1_7_2","first-page":"745","article-title":"Pharmacokinetic studies following systemic and topical administration (14C) bifonazole in man","volume":"33","author":"Patzschke K.","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archderm.1974.01630010038008","article-title":"Percutaneous penetration of hydrocortisone with urea","volume":"109","author":"Feldman R. J.","year":"1974","journal-title":"Arch. Dermatol."}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1997.tb00219.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1997.tb00219.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T18:10:51Z","timestamp":1693591851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1997.tb00219.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":7,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1439-0507.1997.tb00219.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1997.tb00219.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}